Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 6/20 | 0.45 |
| ▸ | OGA | O60502 | 1/20 | 0.42 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | PYGB | P11216 | 1/20 | 0.40 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.36 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.36 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.36 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11391538 | 1.00 | LGALS8 (0.45) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL11389428 | 1.00 | LGALS8 (0.45) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL16227673 | 1.00 | LGALS8 (0.45) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL14975294 | 1.00 | LGALS8 (0.45) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL8214323 | 1.00 | LGALS8 (0.45) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL23026283 | 0.94 | LGALS8 (0.46) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL7919319 | 0.94 | LGALS8 (0.46) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL4606854 | 0.94 | LGALS8 (0.46) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL15353147 | 0.94 | LGALS8 (0.46) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL7927733 | 0.94 | LGALS8 (0.46) | LGALS8OGASLC2A1MAPK1PYGB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0033433-A1 | Macrolide antibiotics, process for their preparation, inter alia by fermentation, and pharmaceutical compositions containing them | SCHERING CORPORATION (US) | 1981-08-12 | — | — | EP | disclosed |